Population-Level Sexual Mixing According to HIV Status and Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Montreal, Canada: Implications for HIV Prevention.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
31 01 2020
Historique:
received: 15 05 2019
revised: 27 09 2019
accepted: 27 09 2019
pubmed: 16 10 2019
medline: 1 5 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

Using cross-sectional survey data (Engage, 2017-2018) from 1,137 men who have sex with men, ≥16 years old, in Montreal, we compared observed human immunodeficiency virus (HIV) seroconcordance in previous-6-months' sexual partnerships with what would have been observed by chance if zero individuals serosorted. Of 5 recent partnerships where both individuals were HIV-negative, we compared observed concordance in preexposure prophylaxis (PrEP) use with the counterfactual if zero individuals selected partners based on PrEP use. We estimated the concordance by chance using a balancing-partnerships approach assuming proportionate mixing. HIV-positive respondents had a higher proportion of HIV-positive partners (66.4%, 95% confidence interval (CI): 64.0, 68.6) than by chance (23.9%, 95% CI: 23.1, 24.7). HIV-negative respondents (both on and not on PrEP) had higher proportions of HIV-negative partners (82.9% (95% CI: 81.1, 84.7) and 90.7% (95% CI: 89.6, 91.7), respectively) compared with by chance (76.1%, 95% CI: 75.3, 76.9); however, those on PrEP had a higher proportion of HIV-positive partners than those not on PrEP (17.1% (95% CI: 15.3, 18.9) vs. 9.3% (95% CI: 8.3, 10.4). Those on PrEP also had a higher proportion of partners on PrEP among their HIV-negative partners (50.6%, 95% CI: 42.5, 58.8) than by chance (28.5%, 95% CI: 27.5, 29.4). The relationship between PrEP and sexual-mixing patterns demonstrated by less population-level serosorting among those on PrEP and PrEP-matching warrants consideration during PrEP roll-out.

Identifiants

pubmed: 31612213
pii: 5587085
doi: 10.1093/aje/kwz231
pmc: PMC7119299
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-54

Subventions

Organisme : CIHR
ID : TE2-138299
Pays : Canada
Organisme : CIHR
ID : CTN 300
Pays : Canada
Organisme : CIHR
ID : FN-13455
Pays : Canada

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

AIDS Behav. 2016 Nov;20(11):2762-2771
pubmed: 26910338
PLoS One. 2017 May 30;12(5):e0178737
pubmed: 28558067
Int J Epidemiol. 2017 Oct 1;46(5):1582-1592
pubmed: 28605503
AIDS Behav. 2016 Jul;20(7):1408-22
pubmed: 26884310
AIDS Care. 2019 Mar;31(3):388-396
pubmed: 30301371
AIDS Patient Care STDS. 2015 Oct;29(10):559-68
pubmed: 26348322
AIDS Educ Prev. 2012 Dec;24(6):564-73
pubmed: 23206204
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
AIDS Behav. 2018 Aug;22(8):2743-2755
pubmed: 29550942
Sex Transm Infect. 2011 Mar;87(2):162-4
pubmed: 21076140
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6743-7
pubmed: 20351258
J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):212-8
pubmed: 18769346
Euro Surveill. 2009 Nov 26;14(47):
pubmed: 19941805
J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):307-14
pubmed: 23846562
Sex Transm Dis. 2010 Jan;37(1):13-7
pubmed: 20118674
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):200-6
pubmed: 26761520
AIDS Patient Care STDS. 2018 Jan;32(1):24-30
pubmed: 29185801
Cult Health Sex. 2014 Feb 26;:
pubmed: 24571102
AIDS Behav. 2017 Oct;21(10):2935-2944
pubmed: 28097616
IMA J Math Appl Med Biol. 1994;11(3):161-92
pubmed: 7822888
Sex Transm Dis. 2018 Jun;45(6):368-373
pubmed: 29465690
AIDS. 2009 Aug 24;23(13):1617-29
pubmed: 19584704
AIDS Behav. 2012 Jan;16(1):121-31
pubmed: 21644001
J Urban Health. 2010 May;87(3):452-66
pubmed: 20217485
Curr HIV/AIDS Rep. 2013 Dec;10(4):305-13
pubmed: 24234489
AIDS Behav. 2017 Oct;21(10):2835-2843
pubmed: 28573378
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25130
pubmed: 30033536
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):17-22
pubmed: 25798149
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):189-97
pubmed: 26885806
Sex Transm Infect. 2009 Oct;85(6):469-76
pubmed: 19505875
AIDS. 2009 Nov 27;23(18):2497-506
pubmed: 19834319
PLoS One. 2016 Sep 22;11(9):e0163159
pubmed: 27657492

Auteurs

Linwei Wang (L)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.

Nasheed Moqueet (N)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.

Gilles Lambert (G)

Institut National de Santé Publique du Québec, Montreal, Quebec, Canada.

Daniel Grace (D)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Ricky Rodrigues (R)

Department of Psychology, Ryerson University, Toronto, Ontario, Canada.

Joseph Cox (J)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Nathan J Lachowsky (NJ)

School of Public Health and Social Policy, University of Victoria, Victoria, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Syed W Noor (SW)

Department of Psychology, Ryerson University, Toronto, Ontario, Canada.

Heather L Armstrong (HL)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
School of Psychology, University of Southampton, Southampton, United Kingdom.

Darrell H S Tan (DHS)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Ann N Burchell (AN)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Huiting Ma (H)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.

Herak Apelian (H)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Jesse Knight (J)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.

Marc Messier-Peet (M)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Jody Jollimore (J)

Community-Based Research Centre, Vancouver, British Columbia, Canada.

Stefan Baral (S)

Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.

Trevor A Hart (TA)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of Psychology, Ryerson University, Toronto, Ontario, Canada.

David M Moore (DM)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Department of Medicine, Division of AIDS, University of British Columbia, Vancouver, British Columbia, Canada.

Sharmistha Mishra (S)

MAP-Centre for Urban Health Solutions, Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH